Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4246694 | 0.86 | FAAH (0.42) | FAAHMAPTL3MBTL1ZDHHC7TSHR | |
| SCHEMBL9683369 | 0.84 | FAAH (0.41) | FAAHMAPTL3MBTL1ZDHHC7TSHR | |
| SCHEMBL4679354 | 0.83 | MAPT (0.42) | FAAHMAPTL3MBTL1TSHRCHRM2 | |
| SCHEMBL19972885 | 0.82 | FAAH (0.40) | FAAHMAPTL3MBTL1 | |
| SCHEMBL28714853 | 0.82 | FAAH (0.40) | FAAHMAPTL3MBTL1 | |
| SCHEMBL19972943 | 0.82 | FAAH (0.40) | FAAHMAPTL3MBTL1 | |
| SCHEMBL19972886 | 0.82 | FAAH (0.40) | FAAHMAPTL3MBTL1 | |
| SCHEMBL28705656 | 0.82 | FAAH (0.40) | FAAHMAPTL3MBTL1 | |
| SCHEMBL2535165 | 0.81 | MAPT (0.41) | FAAHMAPTL3MBTL1TSHRCHRM2 | |
| SCHEMBL4391353 | 0.80 | FAAH (0.46) | FAAHMAPTL3MBTL1TSHRCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117695219-A | X-ray radiation responsive proteolytic targeting chimeric nano micelle and preparation method and application thereof | 中国药科大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20130245286-A1 | PROCESS FOR PRODUCING WINE LACTONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130245286-A1 | PROCESS FOR PRODUCING WINE LACTONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130245287-A1 | PROCESS FOR PRODUCING WINE LACTONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-8481759-B2 | Process for producing wine lactone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| US-8481759-B2 | Process for producing wine lactone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20130030193-A1 | PROCESS FOR PRODUCING WINE LACTONE | TAKASAGO INTERNATIONAL CORPORATION | 2013-01-31 | — | — | US | disclosed |
| US-20130030193-A1 | PROCESS FOR PRODUCING WINE LACTONE | TAKASAGO INTERNATIONAL CORPORATION | 2013-01-31 | — | — | US | disclosed |
| US-6379552-B1 | LIQUID PHASE; USING CYCLODEXTRIN | TORAY INDUSTRIES, INC. (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-0970936-A1 | A method for resolving optical isomers | TORAY INDUSTRIES, INC. (JP) | 2000-01-12 | — | — | EP | disclosed |
| US-5154738-A | Passing mixture through gas chromatography column having dialkyl trifluoroacyl ether derivative of cyclodextrin, eluting separated compounds | ADVANCED SEPARATION TECHNOLOGIES, INC. (US) | 1992-10-13 | — | — | US | disclosed |
| US-5064944-A | Gas Chromatography | ADVANCED SEPARATION TECHNOLOGIES INC. (US) | 1991-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245286-A1 | PROCESS FOR PRODUCING WINE LACTONE | SUCLA2, ADH5, PCCA | FAAH 2263/4885MAPT 3333/4885L3MBTL1 3311/4885 |
| US-20130245287-A1 | PROCESS FOR PRODUCING WINE LACTONE | SUCLA2, ADH5, PCCA | FAAH 2263/4885MAPT 3333/4885L3MBTL1 3311/4885 |
| US-20130030193-A1 | PROCESS FOR PRODUCING WINE LACTONE | SUCLA2, ADH5, PCCA | FAAH 2263/4885MAPT 3333/4885L3MBTL1 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.